Key result
The average LF-HF ratio derived from continuous heart rate variability recordings showed a strong positive correlation with self-reported cancer-related fatigue during the sleep phase.
Why the study?
Standard assessment of cancer-related fatigue relies on subjective patient self-reports, but most patients do not self-report their fatigue levels, prompting the need for an objective monitoring method.
Does continuous heart rate variability monitoring via a wearable PPG device accurately estimate cancer-related fatigue in patients with lung cancer?
Observational (n=12)
No
Does continuous heart rate variability monitoring via a wearable PPG device accurately estimate cancer-related fatigue in patients with lung cancer?
Continuous HRV monitoring via a wearable PPG device can objectively estimate cancer-related fatigue levels in lung cancer patients, closely approximating subjective self-reports.
Answers are grounded in this paper and cite their sources.
Supports wearable HRV monitoring for objective fatigue assessment in lung cancer; leaves open prospective validation before clinical use.
BACKGROUND: Cancer-related fatigue is a serious side effect of cancer, and its treatment can disrupt the quality of life of patients. Clinically, the standard method for assessing cancer-related fatigue relies on subjective experience retrieved from patient self-reports, such as the Brief Fatigue Inventory (BFI). However, most patients do not self-report their fatigue levels. OBJECTIVE: In this study, we aim to develop an objective cancer-related fatigue assessment method to track and monitor fatigue in patients with cancer. METHODS: In total, 12 patients with lung cancer who were undergoing chemotherapy or targeted therapy were enrolled. We developed frequency-domain parameters of heart rate variability (HRV) and BFI based on a wearable-based HRV measurement system. All patients completed the BFI-Taiwan version questionnaire and wore the device for 7 consecutive days to record HRV parameters such as low frequency (LF), high frequency (HF), and LF-HF ratio (LF-HF). Statistical analysis was used to map the correlation between subjective fatigue and objective data. RESULTS: A moderate positive correlation was observed between the average LF-HF ratio and BFI in the sleep phase (ρ=0.86). The mapped BFI score derived by the BFI mapping method could approximate the BFI from the patient self-report. The mean absolute error rate between the subjective and objective BFI scores was 3%. CONCLUSIONS: LF-HF is highly correlated with the cancer-related fatigue experienced by patients with lung cancer undergoing chemotherapy or targeted therapy. Beyond revealing fatigue levels objectively, continuous HRV recordings through the photoplethysmography watch device and the defined parameters (LF-HF) can define the active phase and sleep phase in patients with lung cancer who undergo chemotherapy or targeted chemotherapy, allowing a deduction of their sleep patterns.
No takes yet. Share an insight, caveat, or question.
Shih et al. (2021) conducted an observational in Cancer-related fatigue in lung cancer (n=12). LF-HF ratio derived from continuous HRV recordings was evaluated on Correlation between average LF-HF ratio and Brief Fatigue Inventory (BFI) in the sleep phase (ρ=0.86). The average LF-HF ratio derived from continuous heart rate variability recordings showed a strong positive correlation with self-reported cancer-related fatigue during the sleep phase.
Synapse has enriched 10 related papers. Consider them for comparative context: